Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

计划入组 14,237 人 · 首次发布于 2021 年 12 月 23 日

COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers

计划入组 295 人 · 首次发布于 2021 年 4 月 21 日

High-Dose Moderna mRNA-1273 Booster Study for Lung Transplant Recipients

计划入组 19 人 · 首次发布于 2022 年 3 月 15 日

Moderna COVID-19 Vaccine(Spikevax)

mRNA-1273 + mRNA-1273.351

BCKDHA mRNA therapy (Moderna)

Moderna, Inc.

United States

Moderna US, Inc.

United States

Moderna Biotech Spain, S.L.

Spain

COVID-19 Vaccine Landscape: mRNA and DNA Vaccine Efficacy and Development

Single-Cell Analysis Reveals Immune Dynamics of Moderna COVID-19 Vaccine in Pregnant Women

mRNA Cancer Vaccines: Emerging Prospects in Immunotherapy